首页 > 最新文献

Endocrinologia Diabetes Y Nutricion最新文献

英文 中文
The unavoidable decision for medical societies: Commercial drift or integrity 医学协会不可避免的决定:商业漂移或诚信
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-01 Epub Date: 2025-12-17 DOI: 10.1016/j.endien.2025.501730
Ildefonso Hernández-Aguado , Elisa Chilet-Rosell
{"title":"The unavoidable decision for medical societies: Commercial drift or integrity","authors":"Ildefonso Hernández-Aguado , Elisa Chilet-Rosell","doi":"10.1016/j.endien.2025.501730","DOIUrl":"10.1016/j.endien.2025.501730","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 10","pages":"Article 501730"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fish-eye disease. Altered HDL cholesterol metabolism and corneal involvement: A case report 鱼眼镜头的疾病。高密度脂蛋白胆固醇代谢改变与角膜受累:1例报告。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-01 Epub Date: 2025-10-15 DOI: 10.1016/j.endien.2025.501638
Ana Álvarez ODogherty , Carmen Rodríguez Jiménez , Amaya Belanger-Quintana , Sonia Rodríguez Novoa , Francisco Arrieta Blanco
{"title":"Fish-eye disease. Altered HDL cholesterol metabolism and corneal involvement: A case report","authors":"Ana Álvarez ODogherty , Carmen Rodríguez Jiménez , Amaya Belanger-Quintana , Sonia Rodríguez Novoa , Francisco Arrieta Blanco","doi":"10.1016/j.endien.2025.501638","DOIUrl":"10.1016/j.endien.2025.501638","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 10","pages":"Article 501638"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The overweight and obesity landscape in Spain: Data from the Spanish cohort of the multi-country IMPACT-O study 西班牙的超重和肥胖状况:来自多国IMPACT-O研究的西班牙队列数据
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-01 Epub Date: 2025-12-17 DOI: 10.1016/j.endien.2025.501643
Irene Breton , Igotz Aranbarri , Anastasia Lampropoulou , Jennifer Redondo-Antón , Javier Ágreda , Atif Adam , Esther Artime

Introduction

The epIdeMiology landscape PAtient Care paThways of Obesity (IMPACT-O) study was a multi-country, retrospective cohort study that utilised healthcare databases to determine the landscape/impact of overweight and obesity. Here we describe the sociodemographic, clinical and treatment characteristics of adults with a first record of overweight/obesity or obesity in Spain between 2018 and 2022.

Materials and methods

The IQVIA longitudinal patient database in Spain was used to identify individuals with a first record of overweight/obesity, as determined by diagnosis codes and/or body mass index (BMI) measurements (overweight/obesity cohort: BMI ≥25 kg/m2; obesity cohort: BMI ≥30 kg/m2), in the years 2018–2022. Demographic and clinical parameters, including obesity-related complications (ORCs), as recorded by primary care providers and specialists contributing to the database, were described.

Results

The overweight/obesity cohort included 25,016 individuals, and the obesity cohort 13,441 individuals. Most individuals with overweight/obesity (60.1%) and obesity (63.6%) presented with ≥1 ORCs. The most frequent ORCs among people with obesity were hypertension (25.3%), dyslipidaemia (19.8%), anxiety (19.0%), osteoarthritis (14.3%), low-back pain (10.9%) and depression (10.9%). The proportion of individuals receiving pharmacological therapies with an effect on weight was <1%. There were no records of lifestyle interventions or bariatric surgery in the database for this population.

Conclusions

This study highlights the high ORC burden at first documented diagnosis of overweight/obesity. Very few individuals with obesity in Spain receive pharmacological treatment with an effect on weight. Patient management could be improved by systematically recording all interventions in this population.
肥胖症患者护理路径的流行病学景观(impact - o)研究是一项多国回顾性队列研究,利用医疗保健数据库确定超重和肥胖症的景观/影响。在这里,我们描述了2018年至2022年间西班牙首次有超重/肥胖或肥胖记录的成年人的社会人口学、临床和治疗特征。材料和方法采用西班牙IQVIA纵向患者数据库,通过诊断代码和/或体重指数(BMI)测量(超重/肥胖队列:BMI≥25 kg/m2;肥胖队列:BMI≥30 kg/m2)确定2018-2022年间首次有超重/肥胖记录的个体。描述了由初级保健提供者和提供数据库的专家记录的人口统计学和临床参数,包括肥胖相关并发症(ORCs)。结果超重/肥胖组包括25,016人,肥胖组包括13,441人。大多数超重/肥胖(60.1%)和肥胖(63.6%)患者的orc≥1。肥胖人群中最常见的orc是高血压(25.3%)、血脂异常(19.8%)、焦虑(19.0%)、骨关节炎(14.3%)、腰痛(10.9%)和抑郁症(10.9%)。接受药物治疗对体重有影响的个体比例为1%。数据库中没有针对这一人群的生活方式干预或减肥手术的记录。结论:本研究强调了超重/肥胖首次确诊时的高ORC负担。在西班牙,很少有肥胖者接受对体重有影响的药物治疗。通过系统地记录该人群的所有干预措施,可以改善患者管理。
{"title":"The overweight and obesity landscape in Spain: Data from the Spanish cohort of the multi-country IMPACT-O study","authors":"Irene Breton ,&nbsp;Igotz Aranbarri ,&nbsp;Anastasia Lampropoulou ,&nbsp;Jennifer Redondo-Antón ,&nbsp;Javier Ágreda ,&nbsp;Atif Adam ,&nbsp;Esther Artime","doi":"10.1016/j.endien.2025.501643","DOIUrl":"10.1016/j.endien.2025.501643","url":null,"abstract":"<div><h3>Introduction</h3><div>The epIdeMiology landscape PAtient Care paThways of Obesity (IMPACT-O) study was a multi-country, retrospective cohort study that utilised healthcare databases to determine the landscape/impact of overweight and obesity. Here we describe the sociodemographic, clinical and treatment characteristics of adults with a first record of overweight/obesity or obesity in Spain between 2018 and 2022.</div></div><div><h3>Materials and methods</h3><div>The IQVIA longitudinal patient database in Spain was used to identify individuals with a first record of overweight/obesity, as determined by diagnosis codes and/or body mass index (BMI) measurements (overweight/obesity cohort: BMI ≥25<!--> <!-->kg/m<sup>2</sup>; obesity cohort: BMI ≥30<!--> <!-->kg/m<sup>2</sup>), in the years 2018–2022. Demographic and clinical parameters, including obesity-related complications (ORCs), as recorded by primary care providers and specialists contributing to the database, were described.</div></div><div><h3>Results</h3><div>The overweight/obesity cohort included 25,016 individuals, and the obesity cohort 13,441 individuals. Most individuals with overweight/obesity (60.1%) and obesity (63.6%) presented with ≥1 ORCs. The most frequent ORCs among people with obesity were hypertension (25.3%), dyslipidaemia (19.8%), anxiety (19.0%), osteoarthritis (14.3%), low-back pain (10.9%) and depression (10.9%). The proportion of individuals receiving pharmacological therapies with an effect on weight was &lt;1%. There were no records of lifestyle interventions or bariatric surgery in the database for this population.</div></div><div><h3>Conclusions</h3><div>This study highlights the high ORC burden at first documented diagnosis of overweight/obesity. Very few individuals with obesity in Spain receive pharmacological treatment with an effect on weight. Patient management could be improved by systematically recording all interventions in this population.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 10","pages":"Article 501643"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taxonomic and functional characteristics of the gut microbiota in obesity: A systematic review 肥胖症肠道微生物群的分类和功能特征:系统综述
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.endien.2025.501624
Cristina Mª Díaz Perdigones , Daniel Hinojosa Nogueira , Alba Rodríguez Muñoz , Alba Subiri Verdugo , Alberto Vilches-Pérez , Virginia Mela , Francisco J. Tinahones , Isabel Moreno Indias
Obesity is a growing public health problem. In recent decades, scientific evidence has linked gut microbiota to obesity. This systematic review summarizes current knowledge on the composition and functional differences in gut microbiota between individuals with obesity and those with normal weight. Following PRISMA 2020 recommendations, studies published in adult populations between January 2014 and May 2024 were reviewed. PubMed, Web of Science, and Scopus databases were searched for observational studies that had used advanced sequencing methods, such as 16S rRNA and shotgun metagenomics, to assess gut microbiota. The quality of these studies was also analyzed using the Newcastle-Ottawa scale. Our review of 16 studies shows a reduction in microbial diversity in individuals with obesity. In addition, a higher relative abundance of the phylum Firmicutes, the families Enterobacteriaceae, Gemellaceae, Prevotellaceae, Streptococcaceae and Veillonellaceae, as well as the genera Blautia, Butyricimonas, Collinsella, Megamonas, and Streptococcus, while beneficial bacteria such as the families Porphyromonadaceae and Rikenellaceae, and the genera Bifidobacterium spp. and Faecalibacterium prausnitzii, were depleted. Functional analysis showed a tendency to an increase in metabolic pathways associated with carbohydrate and lipid metabolism, with reduced pathways related to short-chain fatty acid production. Obesity is associated with altered gut microbiota composition and function. However, the variability across studies regarding population characteristics, dietary pattern, and sequencing techniques limits the comparability of findings. Future research should prioritize standardized methodologies and confounding factors to elucidate the role of the gut microbiome in obesity.
肥胖是一个日益严重的公共健康问题。近几十年来,科学证据表明肠道微生物群与肥胖有关。这篇系统综述总结了目前关于肥胖个体和正常体重个体之间肠道微生物群组成和功能差异的知识。根据PRISMA 2020的建议,对2014年1月至2024年5月期间发表的成人研究进行了回顾。PubMed, Web of Science和Scopus数据库检索了使用先进测序方法(如16S rRNA和shotgun宏基因组学)评估肠道微生物群的观察性研究。这些研究的质量也用纽卡斯尔-渥太华量表进行了分析。我们对16项研究的回顾表明,肥胖个体的微生物多样性减少。此外,厚壁菌门、Enterobacteriaceae、Gemellaceae、Prevotellaceae、Streptococcaceae和Veillonellaceae以及Blautia属、Butyricimonas、Collinsella、Megamonas和Streptococcus等有益菌的相对丰度较高,而Porphyromonadaceae和Rikenellaceae、Bifidobacterium spp.和Faecalibacterium prausnitzii等有益菌的相对丰度则相对较少。功能分析显示,与碳水化合物和脂质代谢相关的代谢途径有增加的趋势,与短链脂肪酸产生相关的代谢途径减少。肥胖与肠道菌群组成和功能的改变有关。然而,关于人群特征、饮食模式和测序技术的研究差异限制了研究结果的可比性。未来的研究应优先考虑标准化的方法和混杂因素,以阐明肠道微生物群在肥胖中的作用。
{"title":"Taxonomic and functional characteristics of the gut microbiota in obesity: A systematic review","authors":"Cristina Mª Díaz Perdigones ,&nbsp;Daniel Hinojosa Nogueira ,&nbsp;Alba Rodríguez Muñoz ,&nbsp;Alba Subiri Verdugo ,&nbsp;Alberto Vilches-Pérez ,&nbsp;Virginia Mela ,&nbsp;Francisco J. Tinahones ,&nbsp;Isabel Moreno Indias","doi":"10.1016/j.endien.2025.501624","DOIUrl":"10.1016/j.endien.2025.501624","url":null,"abstract":"<div><div>Obesity is a growing public health problem. In recent decades, scientific evidence has linked gut microbiota to obesity. This systematic review summarizes current knowledge on the composition and functional differences in gut microbiota between individuals with obesity and those with normal weight. Following PRISMA 2020 recommendations, studies published in adult populations between January 2014 and May 2024 were reviewed. PubMed, Web of Science, and Scopus databases were searched for observational studies that had used advanced sequencing methods, such as 16S rRNA and shotgun metagenomics, to assess gut microbiota. The quality of these studies was also analyzed using the Newcastle-Ottawa scale. Our review of 16 studies shows a reduction in microbial diversity in individuals with obesity. In addition, a higher relative abundance of the phylum <em>Firmicutes</em>, <em>the families Enterobacteriaceae</em>, <em>Gemellaceae</em>, <em>Prevotellaceae</em>, <em>Streptococcaceae</em> and <em>Veillonellaceae</em>, as well as the genera <em>Blautia</em>, <em>Butyricimonas</em>, <em>Collinsella</em>, <em>Megamonas</em>, and <em>Streptococcus</em>, while beneficial bacteria such as the families <em>Porphyromonadaceae</em> and <em>Rikenellaceae</em>, and the genera <em>Bifidobacterium</em> spp<em>.</em> and <em>Faecalibacterium prausnitzii</em>, were depleted. Functional analysis showed a tendency to an increase in metabolic pathways associated with carbohydrate and lipid metabolism, with reduced pathways related to short-chain fatty acid production. Obesity is associated with altered gut microbiota composition and function. However, the variability across studies regarding population characteristics, dietary pattern, and sequencing techniques limits the comparability of findings. Future research should prioritize standardized methodologies and confounding factors to elucidate the role of the gut microbiome in obesity.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501624"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP 执行概要。1型糖尿病临床前阶段的筛查、分期和随访:SED、SEEN和SEEP科学学会的共识
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-18 DOI: 10.1016/j.endien.2025.501639
María Asunción Martínez-Brocca , Virginia Bellido , Roque Cardona-Hernandez , Luis Castaño , Ignacio Conget , Alberto Fernández , Ana Lucía Gómez Gila , Isabel Leiva-Gea , Dídac Mauricio
Type 1 diabetes (T1D) is an autoimmune disease whose late diagnosis can lead to serious complications such as diabetic ketoacidosis, especially in children. The presence of specific autoantibodies allows for the identification of a presymptomatic phase, opening the door to screening strategies targeting populations at high genetic risk, such as first-degree relatives. This document presents the consensus recommendations of the Spanish Diabetes Society (SED), the Spanish Society of Endocrinology and Nutrition (SEEN) and the Spanish Society of Paediatric Endocrinology (SEEP) on the screening, staging and monitoring of T1D in preclinical stages. Early identification of the disease will enable a personalised approach to be established, promote health education and, eventually, consider therapeutic interventions that may delay progression to the symptomatic phase. This consensus seeks to establish a common framework for clinical action based on the available evidence, with clear recommendations for its proper implementation.
1型糖尿病(T1D)是一种自身免疫性疾病,其晚期诊断可导致严重并发症,如糖尿病酮症酸中毒,特别是在儿童中。特异性自身抗体的存在允许识别症状前阶段,为针对高遗传风险人群(如一级亲属)的筛查策略打开大门。本文件提出了西班牙糖尿病学会(SED)、西班牙内分泌与营养学会(SEEN)和西班牙儿科内分泌学会(SEEP)关于T1D临床前阶段筛查、分期和监测的共识建议。疾病的早期识别将能够建立个性化的方法,促进健康教育,并最终考虑可能延迟进展到症状阶段的治疗干预措施。这一共识旨在根据现有证据建立临床行动的共同框架,并就如何正确实施提出明确建议。
{"title":"Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP","authors":"María Asunción Martínez-Brocca ,&nbsp;Virginia Bellido ,&nbsp;Roque Cardona-Hernandez ,&nbsp;Luis Castaño ,&nbsp;Ignacio Conget ,&nbsp;Alberto Fernández ,&nbsp;Ana Lucía Gómez Gila ,&nbsp;Isabel Leiva-Gea ,&nbsp;Dídac Mauricio","doi":"10.1016/j.endien.2025.501639","DOIUrl":"10.1016/j.endien.2025.501639","url":null,"abstract":"<div><div>Type 1 diabetes (T1D) is an autoimmune disease whose late diagnosis can lead to serious complications such as diabetic ketoacidosis, especially in children. The presence of specific autoantibodies allows for the identification of a presymptomatic phase, opening the door to screening strategies targeting populations at high genetic risk, such as first-degree relatives. This document presents the consensus recommendations of the Spanish Diabetes Society (SED), the Spanish Society of Endocrinology and Nutrition (SEEN) and the Spanish Society of Paediatric Endocrinology (SEEP) on the screening, staging and monitoring of T1D in preclinical stages. Early identification of the disease will enable a personalised approach to be established, promote health education and, eventually, consider therapeutic interventions that may delay progression to the symptomatic phase. This consensus seeks to establish a common framework for clinical action based on the available evidence, with clear recommendations for its proper implementation.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501639"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From COVID-19 telemedicine to artificial intelligence telemedicine 从COVID-19远程医疗到人工智能远程医疗。
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-15 DOI: 10.1016/j.endien.2025.501595
Ana Zugasti Murillo , Juan José Gorgojo Martínez
{"title":"From COVID-19 telemedicine to artificial intelligence telemedicine","authors":"Ana Zugasti Murillo ,&nbsp;Juan José Gorgojo Martínez","doi":"10.1016/j.endien.2025.501595","DOIUrl":"10.1016/j.endien.2025.501595","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501595"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between fragmented QRS and left ventricular diastolic dysfunction in type 2 diabetes patients with or without microalbuminuria 伴有或不伴有微量白蛋白尿的2型糖尿病患者,碎片化QRS与左室舒张功能障碍之间的关系
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.endien.2025.501623
Lili Wang , Linjun Zheng , Jiayu Hu , Nongnong Zhao
<div><h3>Background</h3><div>Cardiovascular disease (CVD) is the leading cause of death in patients with type 2 diabetes mellitus (T2DM), and left ventricular diastolic dysfunction (LVDD) is considered one of the earliest markers of myocardial dysfunction. Fragmented QRS (fQRS) and microalbuminuria (MAU) are important biomarkers of cardiac electrophysiological changes and CVD, but their relationship with LVDD in T2DM remains unclear. This study aims to explore the impact of fQRS and MAU on LVDD in T2DM patients and to analyze whether the association between fQRS and LVDD differs across varying MAU statuses.</div></div><div><h3>Methods</h3><div>A total of 374 patients with T2DM were ultimately enrolled in this study. Twelve-lead electrocardiography (ECG) and echocardiography were performed, and the patients’ baseline characteristics, laboratory results, and echocardiographic parameters were collected. Univariate and multivariate logistic regression analyses were conducted to assess the association between fQRS, MAU, and LVDD in T2DM patients. A stratified analysis was performed to examine the relationship between fQRS and LVDD across different MAU statuses.</div></div><div><h3>Results</h3><div>The mean age of the T2DM patients was 57.19<!--> <!-->±<!--> <!-->12.47 years, and 62.57% were male. fQRS, MAU, and age were independent risk factors for LVDD in patients with T2DM. The risk of developing LVDD was 3.72 times higher in patients with fQRS compared to those without fQRS [95% CI<!--> <!-->=<!--> <!-->2.125–6.513, <em>P</em> <!--><<!--> <!-->0.0001]. The risk of LVDD was 4.05 times higher in patients with MAU compared to those without MAU [95% CI<!--> <!-->=<!--> <!-->2.252–7.282, <em>P</em> <!--><<!--> <!-->0.0001]. For each additional year of age, the risk of LVDD increased by 5.2% [95% CI<!--> <!-->=<!--> <!-->1.022–1.084, <em>P</em> <!-->=<!--> <!-->0.001]. Stratified analysis based on MAU status revealed that in patients without MAU, the association between fQRS and LVDD was stronger [OR<!--> <!-->=<!--> <!-->7.084, 95% CI<!--> <!-->=<!--> <!-->3.255–15.419, <em>P</em> <!--><<!--> <!-->0.0001]. However, in patients with MAU, the relationship between fQRS and LVDD was no longer significant [OR<!--> <!-->=<!--> <!-->1.499, 95% CI<!--> <!-->=<!--> <!-->0.603–3.722, <em>P</em> <!-->=<!--> <!-->0.383].</div></div><div><h3>Conclusions</h3><div>Our study found that both fQRS and MAU are independent risk factors for LVDD in patients with T2DM. The presence of fQRS increased the risk of LVDD by 3.72 times, while MAU increased the risk by 4.05 times. Stratified analysis further revealed that in patients without MAU, the association between fQRS and LVDD was significantly stronger (OR<!--> <!-->=<!--> <!-->7.084, <em>P</em> <!--><<!--> <!-->0.0001), while in patients with MAU, this association was no longer significant (<em>P</em> <!-->=<!--> <!-->0.383). These findings suggest that combining the detection of fQRS and MAU may provide valuab
背景:心血管疾病(CVD)是2型糖尿病(T2DM)患者死亡的主要原因,而左室舒张功能障碍(LVDD)被认为是心肌功能障碍的最早标志之一。碎片化QRS (fQRS)和微量白蛋白尿(MAU)是心脏电生理变化和CVD的重要生物标志物,但它们与T2DM患者LVDD的关系尚不清楚。本研究旨在探讨fQRS和MAU对T2DM患者LVDD的影响,并分析fQRS与LVDD的相关性是否因MAU状态的不同而不同。方法共纳入374例T2DM患者。行十二导联心电图(ECG)和超声心动图,收集患者的基线特征、实验室结果和超声心动图参数。进行单因素和多因素logistic回归分析,评估T2DM患者fQRS、MAU和LVDD之间的关系。对不同MAU状态下fQRS和LVDD之间的关系进行了分层分析。结果T2DM患者平均年龄57.19±12.47岁,男性占62.57%。fQRS、MAU和年龄是T2DM患者LVDD的独立危险因素。fQRS患者发生LVDD的风险是无fQRS患者的3.72倍[95% CI = 2.125-6.513, P < 0.0001]。MAU患者发生LVDD的风险是无MAU患者的4.05倍[95% CI = 2.252-7.282, P < 0.0001]。每增加一岁,LVDD的风险增加5.2% [95% CI = 1.022-1.084, P = 0.001]。基于MAU状态的分层分析显示,在无MAU患者中,fQRS与LVDD的相关性更强[OR = 7.084, 95% CI = 3.255-15.419, P < 0.0001]。而在MAU患者中,fQRS与LVDD的关系不再显著[OR = 1.499, 95% CI = 0.603-3.722, P = 0.383]。结论本研究发现fQRS和MAU均为T2DM患者LVDD的独立危险因素。fQRS的存在使LVDD的风险增加了3.72倍,MAU的存在使LVDD的风险增加了4.05倍。分层分析进一步发现,在无MAU患者中,fQRS与LVDD的相关性显著增强(OR = 7.084, P < 0.0001),而在有MAU患者中,这种相关性不再显著(P = 0.383)。这些研究结果表明,fQRS和MAU的联合检测可能为T2DM患者心血管风险评估提供有价值的信息,有助于制定个性化的干预策略,最终改善患者预后。
{"title":"The association between fragmented QRS and left ventricular diastolic dysfunction in type 2 diabetes patients with or without microalbuminuria","authors":"Lili Wang ,&nbsp;Linjun Zheng ,&nbsp;Jiayu Hu ,&nbsp;Nongnong Zhao","doi":"10.1016/j.endien.2025.501623","DOIUrl":"10.1016/j.endien.2025.501623","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Cardiovascular disease (CVD) is the leading cause of death in patients with type 2 diabetes mellitus (T2DM), and left ventricular diastolic dysfunction (LVDD) is considered one of the earliest markers of myocardial dysfunction. Fragmented QRS (fQRS) and microalbuminuria (MAU) are important biomarkers of cardiac electrophysiological changes and CVD, but their relationship with LVDD in T2DM remains unclear. This study aims to explore the impact of fQRS and MAU on LVDD in T2DM patients and to analyze whether the association between fQRS and LVDD differs across varying MAU statuses.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A total of 374 patients with T2DM were ultimately enrolled in this study. Twelve-lead electrocardiography (ECG) and echocardiography were performed, and the patients’ baseline characteristics, laboratory results, and echocardiographic parameters were collected. Univariate and multivariate logistic regression analyses were conducted to assess the association between fQRS, MAU, and LVDD in T2DM patients. A stratified analysis was performed to examine the relationship between fQRS and LVDD across different MAU statuses.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The mean age of the T2DM patients was 57.19&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;12.47 years, and 62.57% were male. fQRS, MAU, and age were independent risk factors for LVDD in patients with T2DM. The risk of developing LVDD was 3.72 times higher in patients with fQRS compared to those without fQRS [95% CI&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;2.125–6.513, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.0001]. The risk of LVDD was 4.05 times higher in patients with MAU compared to those without MAU [95% CI&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;2.252–7.282, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.0001]. For each additional year of age, the risk of LVDD increased by 5.2% [95% CI&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;1.022–1.084, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.001]. Stratified analysis based on MAU status revealed that in patients without MAU, the association between fQRS and LVDD was stronger [OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;7.084, 95% CI&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;3.255–15.419, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.0001]. However, in patients with MAU, the relationship between fQRS and LVDD was no longer significant [OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;1.499, 95% CI&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.603–3.722, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.383].&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Our study found that both fQRS and MAU are independent risk factors for LVDD in patients with T2DM. The presence of fQRS increased the risk of LVDD by 3.72 times, while MAU increased the risk by 4.05 times. Stratified analysis further revealed that in patients without MAU, the association between fQRS and LVDD was significantly stronger (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;7.084, &lt;em&gt;P&lt;/em&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;0.0001), while in patients with MAU, this association was no longer significant (&lt;em&gt;P&lt;/em&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.383). These findings suggest that combining the detection of fQRS and MAU may provide valuab","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501623"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hemisoma in which the bioelectrical impedance vector analysis is performed has no influence on outcomes in patients receiving intravenous fluid therapy 在接受静脉输液治疗的患者中,进行生物电阻抗矢量分析的半球瘤对结果没有影响
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.endien.2025.501614
Marina Jara Vidal, Andrés Ruiz de Assín Valverde, Marta Gallach Martínez, Noel Roig Marín, César Gonzalvo Díaz, Rosa Pilar Quílez Toboso, Lourdes García Blasco, Silvia Aznar Rodríguez, José Juan Lozano García, José Joaquín Alfaro Martínez

Introduction

This study investigates the concordance of bioelectrical impedance vector analysis (BIVA) measurements in both hemisomes in patients receiving fluid therapy, since clinical practice suggests performing them in the hemisoma contralateral to that of its administration to avoid interferences.
The primary objective of this study was to evaluate the concordance of phase angle (PhA), resistance and reactance, both standardized by height (Rz/h, Xc/h) between the hemisoma where the patient is receiving iv fluids and the other one.

Methods

Clinical, prospective and descriptive study, which included 100 hospitalized patients with total parenteral nutrition (TPN) or other intravenous fluid therapy. BIVA measurements were taken in both hemisomes and analyzed by means of Bland–Altman plots, Passing–Block test and conditional method agreement trees (COAT).

Results

100 patients were included (57 men and 43 women), with an average age of 67.2 ± 15.1 years. Univariate analysis using the Bland–Altman plot showed no concordance of PhA, Rz/h and Xc/h between both hemisomes in patients who received fluid therapy, but Passing–Block test showed no systematic or proportional differences between hemisomas and multivariate COAT analysis did not show that the specified covariates affected concordance.

Conclusions

No systematic or proportional differences between hemisomas in resistance and reactance has been demonstrated, suggesting the possibility of being able to perform the measurement independently of the side of fluid administration.
本研究调查了接受液体治疗的患者两个半球的生物电阻抗矢量分析(BIVA)测量的一致性,因为临床实践建议在其给药的对侧半球进行测量,以避免干扰。本研究的主要目的是评估相角(PhA)、电阻和电抗的一致性,两者都以高度(Rz/h, Xc/h)来标准化患者接受静脉输液的半球瘤与另一个半球瘤之间的相角、电阻和电抗。方法采用临床、前瞻性和描述性研究,纳入100例接受全肠外营养(TPN)或其他静脉输液治疗的住院患者。在两个半球测量BIVA,并通过Bland-Altman图、pass - block检验和条件方法一致树(COAT)进行分析。结果纳入100例患者(男57例,女43例),平均年龄67.2±15.1岁。使用Bland-Altman图的单变量分析显示,接受液体治疗的患者两个半脑的PhA、Rz/h和Xc/h没有一致性,但通过块检验显示半脑瘤之间没有系统或比例差异,多变量COAT分析没有显示指定的协变量影响一致性。结论:脑半球瘤之间的电阻和电抗没有系统的或比例的差异,这表明可以独立于液体给药方进行测量。
{"title":"The hemisoma in which the bioelectrical impedance vector analysis is performed has no influence on outcomes in patients receiving intravenous fluid therapy","authors":"Marina Jara Vidal,&nbsp;Andrés Ruiz de Assín Valverde,&nbsp;Marta Gallach Martínez,&nbsp;Noel Roig Marín,&nbsp;César Gonzalvo Díaz,&nbsp;Rosa Pilar Quílez Toboso,&nbsp;Lourdes García Blasco,&nbsp;Silvia Aznar Rodríguez,&nbsp;José Juan Lozano García,&nbsp;José Joaquín Alfaro Martínez","doi":"10.1016/j.endien.2025.501614","DOIUrl":"10.1016/j.endien.2025.501614","url":null,"abstract":"<div><h3>Introduction</h3><div>This study investigates the concordance of bioelectrical impedance vector analysis (BIVA) measurements in both hemisomes in patients receiving fluid therapy, since clinical practice suggests performing them in the hemisoma contralateral to that of its administration to avoid interferences.</div><div>The primary objective of this study was to evaluate the concordance of phase angle (PhA), resistance and reactance, both standardized by height (Rz/h, Xc/h) between the hemisoma where the patient is receiving iv fluids and the other one.</div></div><div><h3>Methods</h3><div>Clinical, prospective and descriptive study, which included 100 hospitalized patients with total parenteral nutrition (TPN) or other intravenous fluid therapy. BIVA measurements were taken in both hemisomes and analyzed by means of Bland–Altman plots, Passing–Block test and conditional method agreement trees (COAT).</div></div><div><h3>Results</h3><div>100 patients were included (57 men and 43 women), with an average age of 67.2<!--> <!-->±<!--> <!-->15.1 years. Univariate analysis using the Bland–Altman plot showed no concordance of PhA, Rz/h and Xc/h between both hemisomes in patients who received fluid therapy, but Passing–Block test showed no systematic or proportional differences between hemisomas and multivariate COAT analysis did not show that the specified covariates affected concordance.</div></div><div><h3>Conclusions</h3><div>No systematic or proportional differences between hemisomas in resistance and reactance has been demonstrated, suggesting the possibility of being able to perform the measurement independently of the side of fluid administration.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501614"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurological crisis in tyrosinemia type 1: Essential roles of replacement therapy and nutrition in multidisciplinary management 1型酪氨酸血症的神经危机:替代疗法和营养在多学科管理中的重要作用
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.endien.2025.501534
David Sanchis-Pascual , Agustín Ramos Prol , María Argente Pla , Cristina Montalbán Méndez , Darío Lara Gálvez , Carlos Folgado Bisbal , Montserrat León Fábregas , María Amparo Rubio Broseta , Eva Gascó Santana , Pilar Morillas-Amat , Mónica García Peris , Patricia Correcher Medina , Juan Francisco Merino-Torres
This is the case of a man with hepatorenal tyrosinemia type 1 (HT-1). Following the omission of his usual treatment with nitisinone and the withdrawal of dietary recommendations, the patient developed a severe neurological crisis requiring admission to the intensive care unit (ICU) due to profound diaphragmatic weakness. Despite the initial severity, appropriate management led to a favorable outcome and, eventually, weaning from mechanical ventilation. This case underscores the critical importance of a multidisciplinary approach in the management of inborn errors of metabolism, where nutritional therapy remains the cornerstone of treatment to prevent life-threatening complications.
1型肝肾酪氨酸血症(HT-1)患者。由于忽略了尼替西酮的常规治疗和取消了饮食建议,患者出现了严重的神经危象,由于严重的膈肌无力需要入院重症监护病房(ICU)。尽管最初严重,但适当的管理导致了良好的结果,并最终脱离了机械通气。该病例强调了多学科方法在先天性代谢错误管理中的重要性,其中营养治疗仍然是预防危及生命的并发症的治疗基石。
{"title":"Neurological crisis in tyrosinemia type 1: Essential roles of replacement therapy and nutrition in multidisciplinary management","authors":"David Sanchis-Pascual ,&nbsp;Agustín Ramos Prol ,&nbsp;María Argente Pla ,&nbsp;Cristina Montalbán Méndez ,&nbsp;Darío Lara Gálvez ,&nbsp;Carlos Folgado Bisbal ,&nbsp;Montserrat León Fábregas ,&nbsp;María Amparo Rubio Broseta ,&nbsp;Eva Gascó Santana ,&nbsp;Pilar Morillas-Amat ,&nbsp;Mónica García Peris ,&nbsp;Patricia Correcher Medina ,&nbsp;Juan Francisco Merino-Torres","doi":"10.1016/j.endien.2025.501534","DOIUrl":"10.1016/j.endien.2025.501534","url":null,"abstract":"<div><div>This is the case of a man with hepatorenal tyrosinemia type 1 (HT-1). Following the omission of his usual treatment with nitisinone and the withdrawal of dietary recommendations, the patient developed a severe neurological crisis requiring admission to the intensive care unit (ICU) due to profound diaphragmatic weakness. Despite the initial severity, appropriate management led to a favorable outcome and, eventually, weaning from mechanical ventilation. This case underscores the critical importance of a multidisciplinary approach in the management of inborn errors of metabolism, where nutritional therapy remains the cornerstone of treatment to prevent life-threatening complications.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501534"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxytocin in hypopituitarism: What do we know? 垂体功能减退症中的催产素:我们知道什么?
IF 1.8 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.endien.2025.501637
Anna Aulinas , Elizabeth A. Lawson
{"title":"Oxytocin in hypopituitarism: What do we know?","authors":"Anna Aulinas ,&nbsp;Elizabeth A. Lawson","doi":"10.1016/j.endien.2025.501637","DOIUrl":"10.1016/j.endien.2025.501637","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"72 9","pages":"Article 501637"},"PeriodicalIF":1.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrinologia Diabetes Y Nutricion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1